BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20338599)

  • 21. Spontaneous ovarian hyperstimulation in a naturally conceived pregnancy with uncontrolled hypothyroidism.
    Edwards-Silva RN; Han CS; Hoang Y; Kao LC
    Obstet Gynecol; 2008 Feb; 111(2 Pt 2):498-501. PubMed ID: 18238999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 10% hydroxyethyl starch for plasma expansion in the treatment of severe ovarian hyperstimulation syndrome. A case report.
    Rabinerson D; Ben Rafael Z; Keslin J; Zolotarsky V; Dekel A
    J Reprod Med; 2001 Jan; 46(1):68-70. PubMed ID: 11209636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the ovulatory serum concentration of human chorionic gonadotropin on the incidence of ovarian hyperstimulation syndrome and success rates for in vitro fertilization.
    Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Ross R; Morris S
    Fertil Steril; 2005 Jul; 84(1):93-8. PubMed ID: 16009163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Severe ovarian hyperstimulation syndrome treatment by decompressive paracentesis and self-transfusion of ascitis fluid].
    Kably Ambe A; Ruiz Anguas J; Sánchez de León A
    Ginecol Obstet Mex; 2006 Jun; 74(6):291-9. PubMed ID: 16970114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spontaneous ovarian hyperstimuation syndrome in a naturally conceived singleton pregnancy.
    Ahmed Kamel RM
    Fertil Steril; 2010 Jun; 94(1):351.e1-4. PubMed ID: 20171619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarian hyperstimulation presenting as acute hydrothorax in early intrauterine pregnancy.
    Jiva TM; Israel RH
    Chest; 1993 Jun; 103(6):1924-5. PubMed ID: 8404141
    [No Abstract]   [Full Text] [Related]  

  • 27. Severe ovarian hyperstimulation in a spontaneous singleton pregnancy.
    Rosen GF; Lew MW
    Am J Obstet Gynecol; 1991 Nov; 165(5 Pt 1):1312-3. PubMed ID: 1957853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe ovarian hyperstimulation syndrome, selective embryo reduction and heterotopic pregnancy.
    Mascarenhas L; Eliot B
    Hum Reprod; 1993 Aug; 8(8):1329-31. PubMed ID: 8408537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Some aspects of ovarian hyperstimulation syndrome].
    Kovachev E; Kozovski I; Markova V; Andronov M; Cherneva S; Aleksandrov K
    Akush Ginekol (Sofiia); 2003; 42(6):37-41. PubMed ID: 15067814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Papanikolaou EG; Pozzobon C; Kolibianakis EM; Camus M; Tournaye H; Fatemi HM; Van Steirteghem A; Devroey P
    Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Role of intra-abdominal hypertension in the development and outcome of ovarian hyperstimulation syndrome].
    Marshalov DV; Salov IA; Shifman EM; Petrenko AP; Saliukov RR; Batsunova MO
    Anesteziol Reanimatol; 2013; (6):41-6. PubMed ID: 24749264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aggressive outpatient treatment of ovarian hyperstimulation syndrome with ascites using transvaginal culdocentesis and intravenous albumin minimizes hospitalization.
    Lincoln SR; Opsahl MS; Blauer KL; Black SH; Schulman JD
    J Assist Reprod Genet; 2002 Apr; 19(4):159-63. PubMed ID: 12036082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe ovarian hyperstimulation syndrome with minimal ovarian enlargement: a case report.
    Shand KL; Haines CJ; Loong EP
    Asia Oceania J Obstet Gynaecol; 1992 Sep; 18(3):219-23. PubMed ID: 1449421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coasting vs. cryopreservation of all embryos for prevention of ovarian hyperstimulation syndrome in in vitro fertilization.
    Huddleston HG; Racowsky C; Jackson KV; Fox JH; Ginsburg ES
    Fertil Steril; 2008 Oct; 90(4):1259-62. PubMed ID: 18163999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver dysfunction in severe ovarian hyperstimulation syndrome.
    Obrzut B; Kuczyński W; Grygoruk C; Putowski L; Kluz S; Skret A
    Gynecol Endocrinol; 2005 Jul; 21(1):45-9. PubMed ID: 16048801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on ovarian hyperstimulation syndrome: part 2--clinical signs and treatment.
    Binder H; Dittrich R; Einhaust F; Krieg J; Müller A; Strauss R; Beckmann MW; Cupisti S
    Int J Fertil Womens Med; 2007; 52(2-3):69-81. PubMed ID: 18320864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovarian hyperstimulation syndrome.
    Practice Committee of the American Society for Reproductive Medicine
    Fertil Steril; 2006 Nov; 86(5 Suppl 1):S178-83. PubMed ID: 17055817
    [No Abstract]   [Full Text] [Related]  

  • 38. Unilateral vulvar edema associated with paracentesis in patients with severe ovarian hyperstimulation syndrome. A report of nine cases.
    Luxman D; Cohen JR; Gordon D; Wolman I; Wolf Y; David MP
    J Reprod Med; 1996 Oct; 41(10):771-4. PubMed ID: 8913981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization.
    Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Thomas S
    Fertil Steril; 2008 Jul; 90(1):231-3. PubMed ID: 17981269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Course of mole pregnancy complicated by ovarian hyperstimulation syndrome].
    Diness M; Nilas L
    Ugeskr Laeger; 2012 May; 174(21):1465-7. PubMed ID: 22640792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.